Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Goodwill & Intangibles (2019 - 2025)

Historic Goodwill & Intangibles for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $31.9 million.

  • Eton Pharmaceuticals' Goodwill & Intangibles rose 44455.07% to $31.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.9 million, marking a year-over-year increase of 44455.07%. This contributed to the annual value of $34.9 million for FY2024, which is 63604.14% up from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Goodwill & Intangibles of $31.9 million as of Q3 2025, which was up 44455.07% from $32.9 million recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Goodwill & Intangibles registered a high of $34.9 million during Q4 2024, and its lowest value of $463000.0 during Q3 2021.
  • In the last 5 years, Eton Pharmaceuticals' Goodwill & Intangibles had a median value of $4.7 million in 2023 and averaged $10.1 million.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first crashed by 2434.64% in 2021, then soared by 97408.21% in 2022.
  • Eton Pharmaceuticals' Goodwill & Intangibles (Quarter) stood at $3.6 million in 2021, then skyrocketed by 31.29% to $4.8 million in 2022, then fell by 0.32% to $4.7 million in 2023, then skyrocketed by 636.04% to $34.9 million in 2024, then fell by 8.61% to $31.9 million in 2025.
  • Its last three reported values are $31.9 million in Q3 2025, $32.9 million for Q2 2025, and $33.9 million during Q1 2025.